Premotor symptoms and early diagnosis of Parkinson's disease

International Journal of Neuroscience

Volumn 121, Issue SUPPL. 2, 2011, Pages 3-8

  Adler, Charles H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autonomic disorders; Cognitive impairment; Depression; Olfaction

Indexed keywords

ARTICLE; AUTONOMIC DYSFUNCTION; BEHAVIOR CHANGE; BRADYKINESIA; COGNITIVE DEFECT; EARLY DIAGNOSIS; HUMAN; HYPOSMIA; MUSCLE RIGIDITY; PARKINSON DISEASE; QUALITY OF LIFE; SLEEP DISORDER; SYMPTOM; TREMOR;

AUTONOMIC NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; EARLY DIAGNOSIS; HUMANS; MOOD DISORDERS; OLFACTION DISORDERS; PARKINSON DISEASE;

EID: 80155195718     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2011.620192     Document Type: Article

References (78)

1. Dawson TM, Ko HS, Dawson VL. Genetic animal models of Parkinsons disease. Neuron. 2010;66:646-61.
2. Cookson MR, Bandmann O. Parkinsons disease: insights from pathways. Hum Mol Genet. 2010;19:R21-7.
3. Langston JW. The Parkinsons complex: parkinsonism is just the tip of the iceberg. Ann Neurol. 2006;59:591-6.
4. Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, Johnston AN, Mellick GD, Herting B, Reichmann H, Hummel T. Prevalence of smell loss in Parkinsons disease-a multicenter study. Parkinsonism Relat Disord. 2009;15:490-4.
5. Ansari KA, Johnson A. Olfactory function in patients with Parkinsons disease. J Chron Dis. 1975;28:493-7.
6. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinsons disease. Neurology. 1983;33:943-6.
7. Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinsons disease. J Neurol Neurosurg Psychiatry. 1987;50:88-9.
8. Herting B, Schulze S, Reichmann H, Haehner A, Hummel T. A longitudinal study of olfactory function in patients with idiopathic Parkinsons disease. J Neurol. 2008;255:367-70.
9. Ashendorf L, Constantinou M, Duff K, McCaffrey RJ. Performance of community-dwelling adults ages 55 to 75 on the University of Pennsylvania smell identification test: an item analysis. Appl Neuropsychol. 2005;12:24-9. (Pubitemid 40546159)
10. Lafreniere D, Mann N. Anosmia: loss of smell in the elderly. Otolaryngol Clin North Am. 2009;42:123-31.
11. McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, Smith AD. Anosmia in dementia is associated with Lewy bodies rather than Alzheimers pathology. J Neurol Neurosurg Psychiatry. 2001;70:739-43. (Pubitemid 32554203)
12. Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry. 2009;80:667-70.
13. Garland EM, Raj SR, Peltier AC, Robertson D, Biaggioni I. A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology. 2011;76:456-60.
14. Silveira-Moriyama L, Hughes G, Church A, Ayling H,Williams DR, Petrie A, Holton J, Revesz T, Kingsbury A, Morris HR, Burn DJ, Lees AJ. Hyposmia in progressive supranuclear palsy. Mov Disord. 2010;25:570-7.
15. Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinsons disease. J Neurol Neurosurg Psychiatry. 2004;75:1749-52. (Pubitemid 39611479)
16. Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC. Olfactory function in essential tremor. Neurology. 1992;42: 1631-2.
17. Silveira-Moriyama L, Schwingenschuh P,ODonnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP, Lees AJ. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry. 2009;80:744-8.
18. Shah M, Muhammed N, Findley LJ, Hawkes CH. Olfactory tests in the diagnosis of essential tremor. Parkinsonism Relat Disord. 2008;14:563-8.
19. McKinnon J, Evidente V, Driver-Dunckley E, Premkumar A, Hentz J, Shill H, Sabbagh M, Caviness J, Connor D, Adler C. Olfaction in the elderly: a cross-sectional analysis comparing Parkinsons disease with controls and other disorders. Int J Neurosci. 2010;120:36-9.
20. Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94:176-8. (Pubitemid 14186660)
21. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. Sniffin sticks: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22:39-52. (Pubitemid 27142122)
22. Muller T, Kuhn W, Buttner T, Przuntek H. Distorted colour discrimination in Parkinsons disease is related to severity of the disease. Acta Neurol Scand. 1997;96:293-6. (Pubitemid 27512502)
23. Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinsons disease. Neurology. 1992;42:887-90.
24. Buttner T, Kuhn W, Muller T, Patzold T, Heidbrink K, PrzuntekH. Distorted color discrimination in de novo parkinsonian patients. Neurology. 1995;45:386-7.
25. Hutton JT, Morris JL, Elias JW, Varma R, Poston JN. Spatial contrast sensitivity is reduced in bilateral Parkinsons disease. Neurology. 1991;41:1200-2.
26. Muller T, Kuhn W, Buttner T, Eising E, Coenen H, Haas M, Przuntek H. Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinsons disease. J Neurol. 1998;245:659-64. (Pubitemid 28439031)
27. Muller T, Woitalla D, Peters S, Kohla K, Przuntek H. Progress of visual dysfunction in Parkinsons disease. Acta Neurol Scand. 2002;105:256-60. (Pubitemid 34407227)
28. Diederich NJ, Raman R, Leurgans S, Goetz CG. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol. 2002;59:1249-52. (Pubitemid 34856377)
29. Muller T, Meisel M, Russ H, Przuntek H. Motor impairment influences Farnsworth-Munsell 100 Hue test error scores in Parkinsons disease patients. J Neurol Sci. 2003;213:61-5. (Pubitemid 36842866)
30. Bulens C, Meerwaldt JD, Van der Wildt GJ, Van Deursen JB. Effect of levodopa treatment on contrast sensitivity in Parkinsons disease. Ann Neurol. 1987;22:365-9. (Pubitemid 17137900)
31. Hutton JT, Morris JL, Elias JW. Levodopa improves spatial contrast sensitivity in Parkinsons disease. Arch Neurol. 1993;50:721-4. (Pubitemid 23203577)
32. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004;44:2793-7. (Pubitemid 39165558)
33. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinsons disease. Doc Ophthalmol. 2008;116: 137-46. (Pubitemid 351279805)
34. Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol. 2009;127:737-746.
35. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol. 2011;21(1):24-9.
36. Cubo E, Tedejo RP, Rodriguez Mendez V, Lopez Pena MJ, Trejo Gabriel YGJM. Retina thickness in Parkinsons disease and essential tremor. Mov Disord. 2010;25:2461-2.
37. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW. Frequency of bowel movements and the future risk of Parkinsons disease. Neurology. 2001;57:456-62. (Pubitemid 32757593)
38. Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology. 2009;73:1752-8.
39. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ. Parkinsons disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology. 1987;37:1253-5. (Pubitemid 17130769)
40. Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinsons disease. Gastroenterology. 1984;87:848-56. (Pubitemid 14040457)
41. Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG; Arizona Parkinsons Disease Consortium. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119:689-702.
42. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinsons disease. Neurobiol Aging. 2003;24:197-211. (Pubitemid 36007810)
43. Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG; Arizona Parkinsons Disease Consortium. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 2009;117:613-34.
44. Yoshita M, Hayashi M, Hirai S. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinsons disease. Nucl Med Commun. 1998;19:137-42.
45. Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, Noda T, Nishigaki K, Fujiwara H. Cardiac sympathetic denervation from the early stage of Parkinsons disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med. 2000;41:71-7. (Pubitemid 30046686)
46. Iwasa K, Nakajima K, Yoshikawa H, Tada A, Taki J, Takamori M. Decreased myocardial 123I-MIBG uptake in Parkinsons disease. Acta Neurol Scand. 1998;97:303-6. (Pubitemid 28191922)
47. Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinsons disease. Parkinsonism Relat Disord. 2010;16:252-5.
48. FujishiroH, Frigerio R, Burnett M, Klos KJ, Josephs KA, Delledonne A, Parisi JE, Ahlskog JE, Dickson DW. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinsons disease. Mov Disord. 2008;23:1085-92.
49. Bonuccelli U, Lucetti C, Del Dotto P, Ceravolo R, Gambaccini G, Bernardini S, Rossi G, Piaggesi A. Orthostatic hypotension in de novo Parkinson disease. Arch Neurol. 2003;60:1400-
50. Ferini-Strambi L, FranceschiM, Pinto P, ZucconiM, Smirne S. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology. 1992;38:92-8.
51. Kallio M, Suominen K, Haapaniemi T, Sotaniemi K, Myllyla VV, Astafiev S, Tolonen U. Nocturnal cardiac autonomic regulation in Parkinsons disease. Clin Auton Res. 2004;14:119-24. (Pubitemid 38582296)
52. Mihci E, Kardelen F, Dora B, Balkan S. Orthostatic heart rate variability analysis in idiopathic Parkinsons disease. Acta Neurol Scand. 2006;113:288-93.
53. Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, Curb JD, Petrovitch H. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65:1442-6. (Pubitemid 41552777)
54. Uchiyama M, Isse K, Tanaka K, Yokota N, Hamamoto M, Aida S, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology. 1995;45:709-12.
55. Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology. 2003;61:40-5. (Pubitemid 36818744)
56. Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. 2010;75:494-9.
57. Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleeprelated violence, injury, and REM sleep behavior disorder in Parkinsons disease. Neurology. 1998;51:526-9. (Pubitemid 28406332)
58. Gagnon J, BedardM, Fantini ML, Petit D, PanissetM, Rompre S, Carrier J, Montplaisir J. REM sleep behavior disorder and REM sleep without atonia in Parkinsons disease. Neurology. 2002;59:585-9. (Pubitemid 34919994)
59. Boeve BF, Silber MH, Ferman TJ.REMsleep behavior disorder in Parkinsons disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol. 2004;17:146-57. (Pubitemid 39128224)
60. Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH,Mayer G. Combination of idiopathic REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2005;128:126-37. (Pubitemid 40070527)
61. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006;66: 845-51. (Pubitemid 43739758)
62. Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull. 2006;70:386-90. (Pubitemid 44486569)
63. Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep. 2008;31: 717-23. (Pubitemid 351694259)
64. Nomura T, Inoue Y, Hogl B, Uemura Y, Kitayama M, Abe T, Miyoshi H, Nakashima K. Relationship between (123)I-MIBG scintigrams andREMsleep behavior disorder in Parkinsons disease. Parkinsonism Relat Disord. 2010;16:683-5.
65. Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinsons disease. Mov Disord. 2010;25:2296-
66. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinsons patients in the UK. The CamPaIGN study. Brain. 2004;127:550-60. (Pubitemid 38295472)
67. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease.Neurology. 2005;65:1239-45. (Pubitemid 41508217)
68. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology. 2009;72:1121-6.
69. Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA. Anxiety disorders and depressive disorders preceding Parkinsons disease: a casecontrol study. Mov Disord. 2000;15:669-77. (Pubitemid 30479619)
70. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinsons disease: a register study. Mov Disord. 2003;18:414-8. (Pubitemid 36527282)
71. Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, Elm J. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007;69:342-7. (Pubitemid 47205660)
72. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsons disease. J Neurol Neurosurg Psychiatry. 1988;51:745-52.
73. Jellinger KA. Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm. 2004;111:1219-35. (Pubitemid 39468387)
74. Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayama S. Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol. 2004;63:742-9.
75. Adler CH, Connor DJ, Hentz JG, Sabbagh MN, Caviness JN, Shill HA, Noble B, Beach TG. Incidental Lewy body disease: clinical comparison to a control cohort. Mov Disord. 2010;25:642-6.
76. Beach TG, Adler CH, Sue LI, Peirce JB, Bachalakuri J,Dalsing-Hernandez JE, Lue LF, Caviness JN, ConnorDJ, Sabbagh MN, Walker DG. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol. 2008;115:445-51.
77. Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE. Evidence that incidental Lewy body disease is pre-symptomatic Parkinsons disease. Acta Neuropathol. 2008;115:437-44.
78. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW. Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol. 2008;65:1074-80.